通过结合基因补充和基因组编辑来治疗脊柱肌肉缩的治疗策略
Fumiyuki Hatanaka1,2, Keiichiro Suzuki3,4,5, Kensaku Shojima1,6
1Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA, 92037, USA.
Nature communications
|July 24, 2024
概括
在CRISPR-Cas9基因编辑中,纠正了小鼠的脊髓肌缩 (SMA). 这种同源性独立的有针对性的整合 (HITI) 策略,结合基因补充,为遗传性疾病提供了有希望的长期治疗方法.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 分子生物学分子生物学
- 基因治疗 基因治疗
背景情况:
- 脊髓肌肉缩 (SMA) 是由SMN1基因缺陷引起的遗传性疾病,导致运动神经元损失和肌肉退化.
- 目前的SMA治疗提供了症状缓解,但在确定的长期遗传纠正方面存在困难.
- 基于CRISPR-Cas9的同质独立向集成 (HITI) 能够在各种细胞类型中精确地插入DNA.
研究的目的:
- 评估CRISPR-Cas9 HITI策略的有效性,以纠正SMA引起的突变.
- 在SMA小鼠模型中评估HITI与Smn1cDNA补充相结合的长期治疗潜力.
主要方法:
- 利用CRISPR-Cas9 HITI进行向基因敲击来纠正小鼠SMA突变.
- 与HITI策略一起进行Smn1cDNA补充.
- 在接受治疗的SMA小鼠中评估治疗益处和长期结果.
主要成果:
- 在使用CRISPR-Cas9 HITI系统的小鼠中成功纠正了SMA突变.
- 在用HITI和Smn1cDNA治疗的SMA小鼠中显示出显著的长期治疗益处.
- 在体内验证了HITI策略在分裂和不分裂细胞中的有效性.
结论:
- CRISPR-Cas9 HITI是一种可行的策略,用于纠正像SMA这样的遗传突变.
- HITI和基因补充的组合为长期的SMA治疗提供了一个有希望的方法.
- 这项研究为遗传性疾病开辟了新的治疗途径.
相关概念视频
00:59Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
00:49What is Genetic Engineering?
74.0K
Overview
74.0K
01:21Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
01:59CRISPR
50.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.3K